Skip to content

Huge decline in HIV rates in Zimbabwe driven by fear of infection

What's happening to benefits?

HIV prevention: does scaring people work?

From Kenya to Kennington

Towards a cure for all (part one)

A winter of discontent?

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

Little evidence of transmission of virus that's resistant to newer anti-HIV drugs

Bone loss a general side-effect of HIV therapy, suggests small study